FDA Inspection 1238045 — Boehringer Ingelheim Espana S.A.
The FDA completed an inspection of Boehringer Ingelheim Espana S.A. on Jun 30, 2023 in Sant Cugat Del Valles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 30, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sant Cugat Del Valles (Spain)
Additional details
Mutual Recognition Agreement (MRA)